Low dose, short-term oral methylprednisolone for nasal polyps: A randomized double-blind placebo-controlled trial
- Author:
Natividad A Aguilar
;
Benjamin Jr SA Campomanes
;
Romeo Jr C Sanchez
- Publication Type:Journal Article
- Keywords:
RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL NASAL POLYPOSIS RHINORRHEA NASAL CONGESTION ANOSMIA
- MeSH:
NOSE DISEASES METHYLPREDNISOLONE OLFACTION DISORDERS POLYPS NASAL POLYPS
- From:
Philippine Journal of Otolaryngology Head and Neck Surgery
2006;21(1-2):24-27
- CountryPhilippines
- Language:Filipino
-
Abstract:
Objectives: To determine the efficacy of a 7-day treatment of methylprednisolone 16mg in reducing the size of nasal polyps and on improvement of nasal symptoms. Methods: Design: Randomized double-blind placebo-controlled trial Setting: Out-patient department of the East Avenue Medical Center Patients: Patients 18 years old and above with nasal polyposis determined by history and endoscopic examination Results: There was a significant decrease in polyp size by an average of 16 percent (P < .05) among 12 out of the 23 patients (52.17 percent) in the steroid group versus placebo. The treatment group also exhibited an improvement in nasal symptoms of rhinorrhea, congestion and anosmia compared to the placebo. Conclusion: Medical treatment with oral methylprednisolone given at a low dose of 16 mg for one week resulted in reduction of the size of nasal polyps and improved the symptoms of rhinorrhea, nasal congestion and anosmia. Other associated symptoms like headache, epistaxis, sneezing, itchiness, epiphora, cough, postnasal drip, throat discomfort, facial pain, eyecomplaints and fever did not differ between the steroid and placebo groups. Recommendation: One week of oral steroids can be used to treat nasal polyps initially. If there is response, this mode of management can be combined with a long-term course of intranasal steroid sprays. Patients who do not respond may be referred for surgery. (Author)
